RETINITIS PIGMENTOSA PATHWAY (PW:0001497)
Description
Photoreceptor cells are susceptible to cellular stress - their degeneration and loss is a major cause of blindness. Many genes have identified for the inherited and highly heterogeneous disorders resulting and its patterns of inheritance are varied - some are autosomal dominant (adRP), others are autosomal recessive (arRP), a smaller fraction are X-linked (XLRP) and between 30 to 50% have not yet been classified. Other disorders include Bardet-Biedl syndrome (BBS), macular and age-related macular degeneration (MD, AMD), Leber congenital amaurosis (LCA), cone and cone-rod degeneration (CD, CRD). RP may occur alone or non-syndromic or in combination with other disorders, such as the Usher syndrome. Mutations in the same gene can cause different phenotypes, such as the many mutations in rhodopsin receptor (Rho) that cause adRP or arRP. Many RP mutations are in genes involved in the phototransduction and the metabolic visual cycle pathways. The response to light in the vertebrate retina is mediated by two photoreceptor types: the rods that mediate vision in dim light and the cones that mediate bright light and color vision. Both are G-protein coupled receptors (GPCR) that activate the specific heterotrimeric G protein transducin complex upon their own activation by the visual pigment - the vitamin A-derived 11-cis retinal. The one rod gene (Rho) and three cone genes are collectively known as opsins. Some 200 point mutations have been described for Rho and are associated with both adRP and arRP; they have been categorized into six classes with class I and II being the more common. Upon activation, transducin activates the cGMP phoshodiesterase (Pde) complex; the subsequent decrease in cGMP closes the cGMP-gated cation channels resulting in decreased calcium (Ca2+) influx. Mutations in rod-specific Pde and in cGMP-gated channels are associated with arRP. Decrease in intracellular Ca2+ also promotes the activation of guanylate cyclases and restoration of cGMP levels. The enzymes are constitutively bound to activator proteins (GCAPs), Ca2+ binding proteins that inhibit the cyclases in the presence of Ca2+ but stimulate them in its absence. Mutations in an activator gene have been associated with adRP. GPCR signaling is controlled by several classes of proteins - the kinases that phosphorylate the activated receptors which are then recognized by arrestins whose binding precludes re-binding of G-proteins; at the G-protein level, by GTPase-activating proteins (GAPs) that increase the rate of G-protein GTP hydrolysis leading to inactivation of the Galpha subunit. Sag is a specific arrestin whose mutations have been associated with arRP. In the absence of light, 11-cis retinal acts as an inverse agonist that constrains the receptor in an inactive conformation. Upon light stimulation, the chromophore is isomerized to all-trans retinal. Several enzymes catalyze the transformation of substrates back to the 11-cis retinal in the metabolic visual cycle. Briefly, all-trans retinal is first reduced to all-trans retinol by specific retinol dehydrogenases (RDHs); its transport to the cytoplasmic side of the membrane to serve as the substrate of the enzymes is mediated by the Abca4 transporter. All-trans retinol is esterified to retinyl esters by Lrat. Isomerization to 11-cis retinol is carried out by Rbp65. Retinols are bound by Rbp3 in the extracellular space and by Rbp1 in the retinal pigment epithelium (RPE). Oxidation of 11-cis retinol to 11-cis retinal is carried out by 11-cis retinol dehydrogenases; the newly synthesized chromophore is bound by Rlbp1 which mediates its transport to the receptor site on the membrane. Many of these genes carry mutations and are associated with RP and other forms of photoreceptor degeneration. Approximately one sixth of all RP patients have Usher (USH) syndrome characterized by both vision and hearing loss. Clinically, the three types of Usher - USH1, 2 and 3 have been associated with five, three and one gene, respectively; USH1 is the most severe form. The five genes in USH1 - collectively referred to as the USH1 interactome - are implicated in arRP along with one USH2 and the one USH3 gene. Their associations with auditory mechanotransduction are better known - see the auditory mechanotransduction pathway; the precise roles in visual phototransduction and altered pathways are still elusive but impaired ciliary transport/trafficking is possible. Other RP and photoreceptor degeneration disorders associated genes affect process/pathway categories such as ciliary transport and channel activity, retinal development, metabolism and splicing (several are listed). The expression and targets of several microRNAs are important for the eye. Aberrant expression of several miRNAs has been observed in mouse models of RP where the relatively few studies of miRNAs roles in photoreceptor degeneration have been carried out.
To see the ontology report for annotations, Gviewer and download, click here ...(less)
Pathway Diagram:
Genes in Pathway:
G
Abca4
ATP binding cassette subfamily A member 4
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 2:212,849,470...212,986,730
Ensembl chr 2:212,755,803...212,986,729
G
Best1
bestrophin 1
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 1:216,054,395...216,071,012
Ensembl chr 1:216,054,395...216,070,974
G
Cdh23
cadherin-related 23
ISO
RGD
PMID:20212494
RGD:8547536
NCBI chr20:28,783,124...29,165,624
Ensembl chr20:28,783,564...29,165,332
G
Clrn1
clarin 1
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 2:145,233,941...145,280,855
Ensembl chr 2:145,233,941...145,280,855
G
Cnga1
cyclic nucleotide gated channel subunit alpha 1
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr14:35,920,948...35,959,065
Ensembl chr14:35,926,854...35,959,056
G
Cngb1
cyclic nucleotide gated channel subunit beta 1
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr19:9,732,646...9,798,864
Ensembl chr19:9,732,646...9,797,224
G
Crx
cone-rod homeobox
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 1:85,667,971...85,681,852
Ensembl chr 1:85,667,971...85,681,852
G
Guca1b
guanylate cyclase activator 1B
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 9:21,097,274...21,105,107
Ensembl chr 9:21,097,274...21,105,107
G
Lrat
lecithin retinol acyltransferase
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 2:170,562,148...170,571,212
Ensembl chr 2:170,565,543...170,571,148
G
Myo7a
myosin VIIA
ISO
RGD
PMID:20212494
RGD:8547536
NCBI chr 1:161,755,110...161,825,397
Ensembl chr 1:161,755,110...161,825,365
G
Nr2e3
nuclear receptor subfamily 2, group E, member 3
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 8:69,261,343...69,269,081
Ensembl chr 8:69,261,343...69,269,081
G
Pcdh15
protocadherin related 15
ISO
RGD
PMID:20212494
RGD:8547536
NCBI chr20:13,996,383...15,495,206
Ensembl chr20:13,999,116...15,493,958
G
Pde6a
phosphodiesterase 6A
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr18:56,947,249...57,019,015
Ensembl chr18:56,947,249...57,019,015
G
Pde6b
phosphodiesterase 6B
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr14:1,468,302...1,511,435
Ensembl chr14:1,468,302...1,511,435
G
Pde6g
phosphodiesterase 6G
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr10:106,219,849...106,224,496
Ensembl chr10:106,219,849...106,224,496
G
Prpf31
pre-mRNA processing factor 31
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 1:74,491,247...74,502,922
Ensembl chr 1:74,491,247...74,502,922
G
Prpf8
pre-mRNA processing factor 8
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr10:60,829,778...60,852,887
Ensembl chr10:60,829,778...60,852,887
G
Prph2
peripherin 2
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 9:21,563,770...21,579,074
Ensembl chr 9:21,563,777...21,579,074
G
Rbp3
retinol binding protein 3
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr16:9,273,787...9,282,255
Ensembl chr16:9,273,787...9,282,646
G
Rdh12
retinol dehydrogenase 12
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 6:103,748,457...103,761,379
Ensembl chr 6:103,748,427...103,761,380
G
Rho
rhodopsin
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 4:150,653,205...150,658,367
Ensembl chr 4:150,653,205...150,658,367
G
Rlbp1
retinaldehyde binding protein 1
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 1:142,718,262...142,731,621
Ensembl chr 1:142,718,262...142,731,621
G
Rp1
RP1, axonemal microtubule associated
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 5:19,918,728...20,380,811
Ensembl chr 5:19,918,799...20,377,580
G
Rpe65
retinoid isomerohydrolase RPE65
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 2:251,425,228...251,457,209
Ensembl chr 2:251,425,368...251,457,156
G
Rpgr
retinitis pigmentosa GTPase regulator
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr X:15,238,961...15,299,004
Ensembl chr X:15,239,159...15,298,999
G
Sag
S-antigen visual arrestin
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr 9:95,915,640...95,956,641
Ensembl chr 9:95,917,197...95,956,507
G
Tulp1
TUB like protein 1
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr20:6,413,901...6,425,833
Ensembl chr20:6,413,901...6,425,833
G
Ush1c
USH1 protein network component harmonin
ISO
RGD
PMID:20212494
RGD:8547536
NCBI chr 1:105,831,719...105,880,082
Ensembl chr 1:105,831,723...105,880,082
G
Ush1g
USH1 protein network component sans
ISO
RGD
PMID:20212494
RGD:8547536
NCBI chr10:101,055,923...101,062,753
Ensembl chr10:101,057,208...101,062,564
G
Ush2a
usherin
ISO
RGD
PMID:23701314
RGD:8547535
NCBI chr13:102,368,783...103,035,230
Ensembl chr13:102,368,783...103,035,217
Pathway Gene Annotations
Disease Annotations Associated with Genes in the retinitis pigmentosa pathway
Abca4 age related macular degeneration , age related macular degeneration 14 , age related macular degeneration 2 , Bietti crystalline corneoretinal dystrophy , blindness , cleft lip , Colorectal Neoplasms , cone dystrophy , cone-rod dystrophy , cone-rod dystrophy 3 , congenital stationary night blindness , exudative vitreoretinopathy , Eye Abnormalities , fundus dystrophy , genetic disease , Leber congenital amaurosis , Leber congenital amaurosis 14 , macular degeneration , Mandibulofacial Dysostosis with Mental Deficiency , neuropathy , optic atrophy , retinal degeneration , Retinal Dystrophy, Early Onset Severe , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 19 , retinitis pigmentosa 91 , scotoma , Stargardt disease , Stargardt Disease 1 , Stargardt Disease 3 , Vision Disorders Best1 autosomal dominant vitreoretinochoroidopathy , bestrophinopathy , cone-rod dystrophy , cone-rod dystrophy 6 , fundus dystrophy , genetic disease , macular degeneration , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 50 , Stargardt disease , Stargardt Disease 1 , vitelliform macular dystrophy , Vitelliform Macular Dystrophy 1 , Vitelliform Macular Dystrophy 2 Cdh23 autosomal recessive nonsyndromic deafness , autosomal recessive nonsyndromic deafness 12 , beta-mannosidosis , combined saposin deficiency , Deafness , fundus dystrophy , genetic disease , Hearing Loss , Hearing Loss, Noise-Induced , Hereditary Neoplastic Syndromes , Meniere's disease , multiple intestinal atresia , Neurodevelopmental Disorders , nonsyndromic deafness , Nonsyndromic Sensorineural Hearing Loss , optic atrophy , pituitary adenoma 5 , pneumoconiosis , Presbycusis , retinal disease , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa-deafness syndrome , sensorineural hearing loss , Stickler syndrome , Usher syndrome , Usher syndrome type 1 , Usher syndrome type 1D , Usher syndrome type 2 , Usher syndrome type 2A , Usher Syndrome, Type ID/F Clrn1 branchiootorenal syndrome , fundus dystrophy , genetic disease , Hearing Loss , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 61 , Usher syndrome , Usher syndrome type 3 , Usher syndrome type 3A Cnga1 retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 49 Cngb1 fundus dystrophy , genetic disease , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 45 , retinitis pigmentosa 49 Crx cone-rod dystrophy , cone-rod dystrophy 2 , congenital myopathy 1A , fundus dystrophy , genetic disease , Leber congenital amaurosis , Leber congenital amaurosis 1 , Leber congenital amaurosis 7 , macular degeneration , prostate cancer , retinal degeneration , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 91 , Stargardt disease , Usher syndrome Guca1b fundus dystrophy , Leber congenital amaurosis , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 48 Lrat breast ductal carcinoma , celiac disease , Chemical and Drug Induced Liver Injury , cone-rod dystrophy , Experimental Liver Cirrhosis , Eye Abnormalities , fundus dystrophy , genetic disease , hepatocellular carcinoma , Hereditary Eye Diseases , invasive ductal carcinoma , Leber congenital amaurosis , Leber congenital amaurosis 1 , Leber congenital amaurosis 14 , Leber hereditary optic neuropathy , retinitis pigmentosa , retinitis pigmentosa 1 , Vitamin A Deficiency Myo7a Auditory Neuropathy , autosomal dominant nonsyndromic deafness 11 , autosomal dominant nonsyndromic deafness 80 , autosomal recessive nonsyndromic deafness , autosomal recessive nonsyndromic deafness 2 , autosomal recessive nonsyndromic deafness 7 , Cohen syndrome , congenital nystagmus , COVID-19 , Cutis Verticis Gyrata, Retinitis Pigmentosa, and Sensorineural Deafness , Deafness , fundus dystrophy , genetic disease , Hearing Loss , hereditary breast ovarian cancer syndrome , Leber congenital amaurosis , melanoma , Meniere's disease , nonsyndromic deafness , Nonsyndromic Sensorineural Hearing Loss , optic atrophy , Pendred syndrome , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa-deafness syndrome , sensorineural hearing loss , Usher syndrome , Usher syndrome type 1 , Usher syndrome type 1B , Usher syndrome type 2 , vestibular disease Nr2e3 cone-rod dystrophy , enhanced S-cone syndrome , Eye Abnormalities , fundus dystrophy , genetic disease , Leber congenital amaurosis , ocular albinism 1 , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 37 , Vision Disorders Pcdh15 autistic disorder , autosomal recessive nonsyndromic deafness , autosomal recessive nonsyndromic deafness 23 , cochlear disease , Deafness , fundus dystrophy , genetic disease , Hearing Loss , Meniere's disease , nonsyndromic deafness , Nonsyndromic Sensorineural Hearing Loss , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa-deafness syndrome , schizophrenia , substance-related disorder , Usher syndrome , Usher syndrome type 1 , Usher syndrome type 1D , Usher syndrome type 1F , Usher syndrome type 1G , Usher Syndrome, Type ID/F Pde6a fundus dystrophy , genetic disease , Leber congenital amaurosis , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 43 , Usher syndrome Pde6b Animal Disease Models , cone-rod dystrophy , cone-rod dystrophy 1 , congenital stationary night blindness , congenital stationary night blindness autosomal dominant 2 , fundus dystrophy , genetic disease , High Myopia , macular degeneration , prostate cancer , retinal degeneration , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 40 Pde6g fundus dystrophy , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 57 Prpf31 fundus dystrophy , genetic disease , Leber congenital amaurosis , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 11 Prpf8 Choroideremia , Developmental Disease , fundus dystrophy , genetic disease , human immunodeficiency virus infectious disease , Neurodevelopmental Disorders , Peters anomaly , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 13 , retinitis pigmentosa 14 , stroke Prph2 bestrophinopathy , bone marrow disease , Central Areolar Choroidal Dystrophy 2 , choroid disease , choroidal sclerosis , Choroideremia , cone dystrophy , cone-rod dystrophy , Doyne honeycomb retinal dystrophy , enhanced S-cone syndrome , fundus albipunctatus , fundus dystrophy , genetic disease , Leber congenital amaurosis , macular degeneration , optic atrophy , pancytopenia , partial central choroid dystrophy , patterned macular dystrophy , patterned macular dystrophy 1 , prostate cancer , Radial Drusen, Autosomal Dominant , retinal degeneration , retinal disease , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 7 , Retinitis Pigmentosa, Late-Onset Dominant , Stargardt disease , Stargardt Disease 1 , Usher syndrome , vitelliform macular dystrophy , Vitelliform Macular Dystrophy 2 , Vitelliform Macular Dystrophy 3 Rbp3 autoimmune disease , cone-rod dystrophy , fundus dystrophy , genetic disease , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 66 , uveitis Rdh12 cone-rod dystrophy , fundus dystrophy , Leber congenital amaurosis , Leber congenital amaurosis 13 , Leber hereditary optic neuropathy , retinal degeneration , retinitis pigmentosa , retinitis pigmentosa 1 Rho Coats disease , cone-rod dystrophy , cone-rod dystrophy 14 , Congenital Hypomyelinating Neuropathy 2 , congenital stationary night blindness , congenital stationary night blindness autosomal dominant 1 , fundus albipunctatus , fundus dystrophy , genetic disease , night blindness , occult macular dystrophy , optic atrophy , primary autosomal recessive microcephaly 17 , retinal degeneration , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 4 , Stargardt disease , Stargardt Disease 1 Rlbp1 Bothnia retinal dystrophy , congenital stationary night blindness , Eye Abnormalities , fundus albipunctatus , fundus dystrophy , genetic disease , Hereditary Eye Diseases , macular degeneration , Newfoundland cone-rod dystrophy , night blindness , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 Rp1 breast ductal carcinoma , fundus dystrophy , genetic disease , HYPERTRIGLYCERIDEMIA 1 , invasive ductal carcinoma , Leber hereditary optic neuropathy , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 , Vision Disorders Rpe65 adrenocorticotropic hormone deficiency , autistic disorder , basal cell carcinoma , blindness , cone-rod dystrophy , cone-rod dystrophy 15 , congenital nystagmus , Developmental Disabilities , Experimental Autoimmune Uveitis , Experimental Diabetes Mellitus , Eye Abnormalities , fundus dystrophy , genetic disease , Hereditary Eye Diseases , Joubert syndrome 9 , Leber congenital amaurosis , Leber congenital amaurosis 2 , Leber hereditary optic neuropathy , Neurodevelopmental Disorders , pathologic nystagmus , retinal degeneration , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 20 , retinitis pigmentosa 87 , squamous cell carcinoma Rpgr Ciliary Motility Disorders , cone dystrophy , cone-rod dystrophy , congenital stationary night blindness , esophageal atresia , fundus dystrophy , Hearing Loss , Leber congenital amaurosis , macular degeneration , male infertility , optic atrophy , primary ciliary dyskinesia , Respiratory Tract Infections , retinal degeneration , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 3 , retinitis pigmentosa 6 , X-linked atrophic macular degeneration , X-linked cone-rod dystrophy 1 , X-linked retinitis pigmentosa and sinorespiratory infections Sag cone dystrophy , congenital stationary night blindness , fundus dystrophy , genetic disease , hereditary night blindness , Oguchi disease-1 , Oguchi disease-2 , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 47 , retinitis pigmentosa 96 , uveitis Tulp1 brachydactyly , Eye Abnormalities , fundus dystrophy , genetic disease , Leber congenital amaurosis , Leber congenital amaurosis 1 , Leber congenital amaurosis 15 , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 14 , Stargardt disease Ush1c autosomal recessive nonsyndromic deafness , Autosomal Recessive Nonsyndromic Deafness 18 , autosomal recessive nonsyndromic deafness 18A , fundus dystrophy , genetic disease , Hearing Loss , Meniere's disease , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa-deafness syndrome , sensorineural hearing loss , Usher syndrome , Usher syndrome type 1 , Usher syndrome type 1B , Usher syndrome type 1C , Usher syndrome type 2 Ush1g autosomal recessive nonsyndromic deafness , Autosomal Recessive Nonsyndromic Deafness 18 , autosomal recessive nonsyndromic deafness 18A , Deafness , fundus dystrophy , genetic disease , Hearing Loss , Nonsyndromic Sensorineural Hearing Loss , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa-deafness syndrome , Usher syndrome , Usher syndrome type 1 , Usher syndrome type 1G Ush2a autism spectrum disorder , autosomal dominant nonsyndromic deafness 36 , Bardet-Biedl syndrome , blindness , cone-rod dystrophy , cone-rod dystrophy 3 , congenital stationary night blindness , fundus dystrophy , genetic disease , Hearing Loss , Joubert syndrome , Leber congenital amaurosis , macular degeneration , nonsyndromic deafness , optic atrophy , prostate cancer , Pulmonary Surfactant Metabolism Dysfunction 2 , retinal degeneration , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 39 , retinitis pigmentosa-deafness syndrome , sensorineural hearing loss , Usher syndrome , Usher syndrome type 1 , Usher syndrome type 2 , Usher syndrome type 2A , Usher syndrome type 3A , Vision Disorders
adrenocorticotropic hormone deficiency Rpe65 age related macular degeneration Abca4 age related macular degeneration 14 Abca4 age related macular degeneration 2 Abca4 Animal Disease Models Pde6b Auditory Neuropathy Myo7a autism spectrum disorder Ush2a autistic disorder Pcdh15 , Rpe65 autoimmune disease Rbp3 autosomal dominant nonsyndromic deafness 11 Myo7a autosomal dominant nonsyndromic deafness 36 Ush2a autosomal dominant nonsyndromic deafness 80 Myo7a autosomal dominant vitreoretinochoroidopathy Best1 autosomal recessive nonsyndromic deafness Cdh23 , Myo7a , Pcdh15 , Ush1c , Ush1g autosomal recessive nonsyndromic deafness 12 Cdh23 Autosomal Recessive Nonsyndromic Deafness 18 Ush1c , Ush1g autosomal recessive nonsyndromic deafness 18A Ush1c , Ush1g autosomal recessive nonsyndromic deafness 2 Myo7a autosomal recessive nonsyndromic deafness 23 Pcdh15 autosomal recessive nonsyndromic deafness 7 Myo7a Bardet-Biedl syndrome Ush2a basal cell carcinoma Rpe65 bestrophinopathy Best1 , Prph2 beta-mannosidosis Cdh23 Bietti crystalline corneoretinal dystrophy Abca4 blindness Abca4 , Rpe65 , Ush2a bone marrow disease Prph2 Bothnia retinal dystrophy Rlbp1 brachydactyly Tulp1 branchiootorenal syndrome Clrn1 breast ductal carcinoma Lrat , Rp1 celiac disease Lrat Central Areolar Choroidal Dystrophy 2 Prph2 Chemical and Drug Induced Liver Injury Lrat choroid disease Prph2 choroidal sclerosis Prph2 Choroideremia Prpf8 , Prph2 Ciliary Motility Disorders Rpgr cleft lip Abca4 Coats disease Rho cochlear disease Pcdh15 Cohen syndrome Myo7a Colorectal Neoplasms Abca4 combined saposin deficiency Cdh23 cone dystrophy Abca4 , Prph2 , Rpgr , Sag cone-rod dystrophy Abca4 , Best1 , Crx , Lrat , Nr2e3 , Pde6b , Prph2 , Rbp3 , Rdh12 , Rho , Rpe65 , Rpgr , Ush2a cone-rod dystrophy 1 Pde6b cone-rod dystrophy 14 Rho cone-rod dystrophy 15 Rpe65 cone-rod dystrophy 2 Crx cone-rod dystrophy 3 Abca4 , Ush2a cone-rod dystrophy 6 Best1 Congenital Hypomyelinating Neuropathy 2 Rho congenital myopathy 1A Crx congenital nystagmus Myo7a , Rpe65 congenital stationary night blindness Abca4 , Pde6b , Rho , Rlbp1 , Rpgr , Sag , Ush2a congenital stationary night blindness autosomal dominant 1 Rho congenital stationary night blindness autosomal dominant 2 Pde6b COVID-19 Myo7a Cutis Verticis Gyrata, Retinitis Pigmentosa, and Sensorineural Deafness Myo7a Deafness Cdh23 , Myo7a , Pcdh15 , Ush1g Developmental Disabilities Rpe65 Developmental Disease Prpf8 Doyne honeycomb retinal dystrophy Prph2 enhanced S-cone syndrome Nr2e3 , Prph2 esophageal atresia Rpgr Experimental Autoimmune Uveitis Rpe65 Experimental Diabetes Mellitus Rpe65 Experimental Liver Cirrhosis Lrat exudative vitreoretinopathy Abca4 Eye Abnormalities Abca4 , Lrat , Nr2e3 , Rlbp1 , Rpe65 , Tulp1 fundus albipunctatus Prph2 , Rho , Rlbp1 fundus dystrophy Abca4 , Best1 , Cdh23 , Clrn1 , Cngb1 , Crx , Guca1b , Lrat , Myo7a , Nr2e3 , Pcdh15 , Pde6a , Pde6b , Pde6g , Prpf31 , Prpf8 , Prph2 , Rbp3 , Rdh12 , Rho , Rlbp1 , Rp1 , Rpe65 , Rpgr , Sag , Tulp1 , Ush1c , Ush1g , Ush2a genetic disease Abca4 , Best1 , Cdh23 , Clrn1 , Cngb1 , Crx , Lrat , Myo7a , Nr2e3 , Pcdh15 , Pde6a , Pde6b , Prpf31 , Prpf8 , Prph2 , Rbp3 , Rho , Rlbp1 , Rp1 , Rpe65 , Sag , Tulp1 , Ush1c , Ush1g , Ush2a Hearing Loss Cdh23 , Clrn1 , Myo7a , Pcdh15 , Rpgr , Ush1c , Ush1g , Ush2a Hearing Loss, Noise-Induced Cdh23 hepatocellular carcinoma Lrat hereditary breast ovarian cancer syndrome Myo7a Hereditary Eye Diseases Lrat , Rlbp1 , Rpe65 Hereditary Neoplastic Syndromes Cdh23 hereditary night blindness Sag High Myopia Pde6b human immunodeficiency virus infectious disease Prpf8 HYPERTRIGLYCERIDEMIA 1 Rp1 invasive ductal carcinoma Lrat , Rp1 Joubert syndrome Ush2a Joubert syndrome 9 Rpe65 Leber congenital amaurosis Abca4 , Crx , Guca1b , Lrat , Myo7a , Nr2e3 , Pde6a , Prpf31 , Prph2 , Rdh12 , Rpe65 , Rpgr , Tulp1 , Ush2a Leber congenital amaurosis 1 Crx , Lrat , Tulp1 Leber congenital amaurosis 13 Rdh12 Leber congenital amaurosis 14 Abca4 , Lrat Leber congenital amaurosis 15 Tulp1 Leber congenital amaurosis 2 Rpe65 Leber congenital amaurosis 7 Crx Leber hereditary optic neuropathy Lrat , Rdh12 , Rp1 , Rpe65 macular degeneration Abca4 , Best1 , Crx , Pde6b , Prph2 , Rlbp1 , Rpgr , Ush2a male infertility Rpgr Mandibulofacial Dysostosis with Mental Deficiency Abca4 melanoma Myo7a Meniere's disease Cdh23 , Myo7a , Pcdh15 , Ush1c multiple intestinal atresia Cdh23 Neurodevelopmental Disorders Cdh23 , Prpf8 , Rpe65 neuropathy Abca4 Newfoundland cone-rod dystrophy Rlbp1 night blindness Rho , Rlbp1 nonsyndromic deafness Cdh23 , Myo7a , Pcdh15 , Ush2a Nonsyndromic Sensorineural Hearing Loss Cdh23 , Myo7a , Pcdh15 , Ush1g occult macular dystrophy Rho ocular albinism 1 Nr2e3 Oguchi disease-1 Sag Oguchi disease-2 Sag optic atrophy Abca4 , Cdh23 , Clrn1 , Cngb1 , Myo7a , Nr2e3 , Pcdh15 , Prph2 , Rbp3 , Rho , Rlbp1 , Rp1 , Rpgr , Ush1c , Ush1g , Ush2a pancytopenia Prph2 partial central choroid dystrophy Prph2 pathologic nystagmus Rpe65 patterned macular dystrophy Prph2 patterned macular dystrophy 1 Prph2 Pendred syndrome Myo7a Peters anomaly Prpf8 pituitary adenoma 5 Cdh23 pneumoconiosis Cdh23 Presbycusis Cdh23 primary autosomal recessive microcephaly 17 Rho primary ciliary dyskinesia Rpgr prostate cancer Crx , Pde6b , Prph2 , Ush2a Pulmonary Surfactant Metabolism Dysfunction 2 Ush2a Radial Drusen, Autosomal Dominant Prph2 Respiratory Tract Infections Rpgr retinal degeneration Abca4 , Crx , Pde6b , Prph2 , Rdh12 , Rho , Rpe65 , Rpgr , Ush2a retinal disease Cdh23 , Prph2 Retinal Dystrophy, Early Onset Severe Abca4 retinitis pigmentosa Abca4 , Best1 , Cdh23 , Clrn1 , Cnga1 , Cngb1 , Crx , Guca1b , Lrat , Myo7a , Nr2e3 , Pcdh15 , Pde6a , Pde6b , Pde6g , Prpf31 , Prpf8 , Prph2 , Rbp3 , Rdh12 , Rho , Rlbp1 , Rp1 , Rpe65 , Rpgr , Sag , Tulp1 , Ush1c , Ush1g , Ush2a retinitis pigmentosa 1 Abca4 , Best1 , Cdh23 , Clrn1 , Cnga1 , Cngb1 , Crx , Guca1b , Lrat , Myo7a , Nr2e3 , Pcdh15 , Pde6a , Pde6b , Pde6g , Prpf31 , Prpf8 , Prph2 , Rbp3 , Rdh12 , Rho , Rlbp1 , Rp1 , Rpe65 , Rpgr , Sag , Tulp1 , Ush1c , Ush1g , Ush2a retinitis pigmentosa 11 Prpf31 retinitis pigmentosa 13 Prpf8 retinitis pigmentosa 14 Prpf8 , Tulp1 retinitis pigmentosa 19 Abca4 retinitis pigmentosa 20 Rpe65 retinitis pigmentosa 3 Rpgr retinitis pigmentosa 37 Nr2e3 retinitis pigmentosa 39 Ush2a retinitis pigmentosa 4 Rho retinitis pigmentosa 40 Pde6b retinitis pigmentosa 43 Pde6a retinitis pigmentosa 45 Cngb1 retinitis pigmentosa 47 Sag retinitis pigmentosa 48 Guca1b retinitis pigmentosa 49 Cnga1 , Cngb1 retinitis pigmentosa 50 Best1 retinitis pigmentosa 57 Pde6g retinitis pigmentosa 6 Rpgr retinitis pigmentosa 61 Clrn1 retinitis pigmentosa 66 Rbp3 retinitis pigmentosa 7 Prph2 retinitis pigmentosa 87 Rpe65 retinitis pigmentosa 91 Abca4 , Crx retinitis pigmentosa 96 Sag Retinitis Pigmentosa, Late-Onset Dominant Prph2 retinitis pigmentosa-deafness syndrome Cdh23 , Myo7a , Pcdh15 , Ush1c , Ush1g , Ush2a schizophrenia Pcdh15 scotoma Abca4 sensorineural hearing loss Cdh23 , Myo7a , Ush1c , Ush2a squamous cell carcinoma Rpe65 Stargardt disease Abca4 , Best1 , Crx , Prph2 , Rho , Tulp1 Stargardt Disease 1 Abca4 , Best1 , Prph2 , Rho Stargardt Disease 3 Abca4 Stickler syndrome Cdh23 stroke Prpf8 substance-related disorder Pcdh15 Usher syndrome Cdh23 , Clrn1 , Crx , Myo7a , Pcdh15 , Pde6a , Prph2 , Ush1c , Ush1g , Ush2a Usher syndrome type 1 Cdh23 , Myo7a , Pcdh15 , Ush1c , Ush1g , Ush2a Usher syndrome type 1B Myo7a , Ush1c Usher syndrome type 1C Ush1c Usher syndrome type 1D Cdh23 , Pcdh15 Usher syndrome type 1F Pcdh15 Usher syndrome type 1G Pcdh15 , Ush1g Usher syndrome type 2 Cdh23 , Myo7a , Ush1c , Ush2a Usher syndrome type 2A Cdh23 , Ush2a Usher syndrome type 3 Clrn1 Usher syndrome type 3A Clrn1 , Ush2a Usher Syndrome, Type ID/F Cdh23 , Pcdh15 uveitis Rbp3 , Sag vestibular disease Myo7a Vision Disorders Abca4 , Nr2e3 , Rp1 , Ush2a Vitamin A Deficiency Lrat vitelliform macular dystrophy Best1 , Prph2 Vitelliform Macular Dystrophy 1 Best1 Vitelliform Macular Dystrophy 2 Best1 , Prph2 Vitelliform Macular Dystrophy 3 Prph2 X-linked atrophic macular degeneration Rpgr X-linked cone-rod dystrophy 1 Rpgr X-linked retinitis pigmentosa and sinorespiratory infections Rpgr